Rheumatoid Arthritis Clinical Trials in New York

Showing 2221-2240 of 3,596 trials

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

NCT04366830

The objectives of this intermediate-size expanded access protocol are to assess the safety and efficacy of remestemcel-L in participants with ARDS due to coronavirus infection 2019 (COVID-19).

Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19

Mesoblast International Sàrl

New York, New York, United States

COMPLETEDPhase 2< 1 mile

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452

The purpose of this study is to investigate the effect on the frequency of all seizures (convulsive and drop) in participants treated with TAK-935 compared to placebo.

EpilepsyDravet SyndromeLennox-Gastaut Syndrome

Takeda141 participantsStarted Aug 2018

Phoenix, Arizona, United States • Los Angeles, California, United States • Aurora, Colorado, United States +41 more locations

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Rheumatoid Arthritis Trials in Other Cities

A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

Start Time Optimization of Biologics in Polyarticular JIA

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Mifepristone Induction for Fetal Demise

Application of Cervical Elastography in Obstetrics

Evaluation of the Benefits of FloraGLO™ Lutein on Skin Health

Surgical Pain After Inguinal Hernia Repair (SPAIHR)

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

A-Health RCT: Effects of Participatory Art-based Activity on Health of Older Community Dwellers

P4 (Pregabalin for Peripheral Posttraumatic Pain)

Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.

Other Conditions in New York